NCT01962987 2020-07-20
A Study Comparing Diclofenac Sodium Gel 3% to SolarazeĀ® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis
Actavis Inc.
Phase 3 Completed
Clinical Trials
3 trialsNCT01982539 2020-05-07
Safety and Tolerability of ZipsorĀ® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute
Depomed
Phase 4 Completed
NCT02287350 2017-07-11
Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain
Depomed
Phase 4 Completed